Compagnie Lombard Odier SCmA’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-43,428
Closed -$7.44M 728
2021
Q1
$7.44M Buy
+43,428
New +$7.44M 0.16% 95